Brookstone Capital Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-4,756
Closed -$233K – 465
2019
Q3
$233K Sell
4,756
-4,080
-46% -$205K 0.01% 382
2019
Q2
$461K Sell
8,836
-1,632
-16% -$82.2K 0.03% 283
2019
Q1
$520K Buy
+10,468
New +$471K 0.03% 211
2018
Q4
– Sell
-11,940
Closed -$609K – 393
2018
Q3
$609K Sell
11,940
-1,572
-12% -$69.6K 0.05% 219
2018
Q2
$500K Buy
13,512
+1,704
+14% +$65.1K 0.04% 231
2018
Q1
$446K Buy
11,808
+808
+7% +$28.6K 0.04% 192
2017
Q4
$356K Sell
11,000
-120
-1% -$3.81K 0.03% 239
2017
Q3
$336K Buy
11,120
+1,092
+11% +$32.4K 0.03% 247
2017
Q2
$295K Buy
+10,028
New +$274K 0.03% 221
2015
Q4
– Sell
-40
Closed -$1K – 803
2015
Q3
$1K Hold
40
– – ﹤0.01% 1853
2015
Q2
$1K Buy
+40
New +$999 ﹤0.01% 2017

Other funds holding TECH

Brookstone Capital Management's TECH Position: Q4 2019 in Review

Brookstone Capital Management sold out of Bio-Techne (TECH) in Q4 2019, closing a stake of 4,756 shares — an estimated $233K sold.

Brookstone Capital Management first reported a position in TECH in Q2 2015 and held it in 11 quarters. The position peaked at $609K in Q3 2018. 376 funds tracked by Wall St. Rank hold TECH as of Q4 2019.

  • Brookstone Capital Management reported no remaining Bio-Techne position as of Q4 2019 after selling out during the quarter.
  • Brookstone Capital Management sold 4,756 Bio-Techne shares in Q4 2019, an estimated $233K.
  • Brookstone Capital Management first reported a position in Bio-Techne in Q2 2015 and held it in 11 quarters.
  • Brookstone Capital Management's Bio-Techne position peaked at $609K in Q3 2018.
  • 376 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2019.

Based on Brookstone Capital Management's 13F filing for Q4 2019, filed 29 Jan 2020.